Original Research
Accepted on 09 Feb 2026
A Compass in the Challenge: The CALLY Index as a Prognostic Biomarker in Advanced Cholangiocarcinoma Treated with Chemoimmunotherapy A Retrospective Propensity Score-Matched Cohort Study
in Cancer Immunity and Immunotherapy